An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett Syndrome
Clinical trial NCT04988867 · TERMINATED
Trial details
- NCT number
- NCT04988867
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-22
- Primary completion
- 2023-05-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.